Ahmed, R., Devenney, E. M., Irish, M., Ittner, A., Naismith, S., Ittner, L. M., …Kiernan, M. C. (2016). Neuronal network disintegration: Common pathways linking neurodegenerative diseases. Journal of Neurology, Neurosurgery & Psychiatry. 87, 1234–1241
Andrews-Hanna, J. R., Snyder, A. Z., Vincent, J. L., Lustig, C., Head, D., Raichle, M. E., & Buckner, R. L. (2007). Disruption of large-scale brain systems in advanced aging. Neuron, 56, 924–935
Barnes D. E., Yaffe K., (2011) The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurology 10: 819–828
Barnett J. H., Hachinski V., Blackwell A. D., (2013) Cognitive health begins at conception: Addressing dementia as a lifelong and preventable condition. BMC Medicine 11: 246
Beer Ch., Flicker L., Horner B., Bretland N., Scherer S., Nicola T., Almeida O. P., (2010) Factors associated with self and informant ratings of the quality of life of people with dementia living in care facilities: A cross sectional study. PLoS ONE 5: e15621
Blazer D. G., Yaffe K., Liverman C. T., (2015) Cognitive aging. Progress in understanding and opportunities for action, Washington, DC: The National Academies Press
Bozoki A. C., An H., Bozoki E. S., Little R. J., (2009) The existence of cognitive plateaus in Alzheimer's disease. Alzheimer's & Dementia 5: 470–478
Brayne C., Davis D., (2012) Making Alzheimer’s and dementia research fit for populations. Lancet 380: 1441–1443
Brayne C., Gao L., Dewey M., Matthews F. E., Medical Research Council Cognitive Function, Aging Study Investigators (2006) Dementia before death in ageing societies. The promise of prevention and the reality. PLoS Medicine 3: 1922–1929
Castellani R. J., Perry G., (2012) Pathogenesis and disease-modifying therapy in Alzheimer’s disease: The flat line of progress. Archives of Medical Research 43: 694–698
Chen M., Maleski J., Sawmiller D. R., (2011) Scientific truth or false hope? Understanding Alzheimer‘s disease from an aging perspective. Journal of Alzheimer’s Disease 24: 3–10
Clare L., Linden D. E. J., Woods R. T., Evans S. J., Parkinson C. H., van Paasschen J., Rugg M. D., (2010) Goal-oriented cognitive rehabilitation for people with early-stage Alzheimer disease: A single-blind randomized controlled trial of efficacy. American Journal of Geriatric Psychiatry 18: 928–939
Cooper C., Mukadam N., Katona C., Lyketsos C. G., Blazer D., Rabins P., Livingston G., (2013) Systematic review of the effectiveness of pharmacological interventions to improve quality of life and well-being in people with dementia. American Journal of Geriatric Psychiatry 21: 173–183
Deckers K., van Boxel M. P., Schipers O. J., de Vugt M., Munoz Sanchez J. L., Anstey K. J., Köhler S., (2015) Target risk factors for dementia prevention: A systematic review and Delphi consensus study on the evidence from observational studies. International Journal of Geriatric Psychiatry 30: 234–246
Dugger B. N., Hentz J. G., Adler C. H., Sabbagh M. N., Shill H. A., Jacobson S., Beach T. G., (2014) Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers. Journal of Neuropathology and Experimental Neurology 73: 244–252
Fjell A. M., McEvoy L., Holland D., Dale A. M., Walhovd K. B., (2014) What is normal in normal aging? Effects of aging, amyloid, and Alzheimer’s disease on the cerebral cortex and the hippocampus. Progress in Neurobiology 117: 20–40
Friedland R. P., Nandi S., (2013) A modest proposal for a longitudinal study of dementia prevention (with apologies to Jonathan Swift, 1729). Journal of Alzheimer’s Disease 33: 313–315
Herrup K., (2010) Reimagining Alzheimer’s disease. An age-based hypothesis. The Journal of Neuroscience 15: 16755–16762
Jellinger K. A., Attems J., (2015) Challenge of multimorbidity of the aging brain: A critical update. Journal of Neural Transmission 122: 505–521
Kaduszkiewicz H., Eisele M., Wiese M., Prokein J., Luppa M., Luck T., Riedel-Heller S. G., (2014) Prognosis of mild cognitive impairment in general practice of the German AgeCoDe study. Annals of Family Medicine 12: 158–165
Katz S., Calasanti T., (2015) Critical perspectives on successful aging: Does it “appeal more than it illuminates”? Gerontologist 55: 26–33
Kinderman P., (2005) A psychological model of mental disorder. Harvard Review of Psychiatry 13: 206–217
Kinderman P., (2014) A prescription for psychiatry: Why we need a whole new approach to mental health and wellbeing, Basingstoke, UK: Palgrave Macmillan
Kinderman P., (2015) Imagine there’s no diagnosis, it’s easy if you try. Psychopathology Review 2: 154–161
Kling M. A., Trojanowski J. Q., Wolk D. A., Lee V. M., Arnold S. E., (2013) Vascular disease and dementias: Paradigm shifts to drive research in new directions. Alzheimer’s & Dementia 9: 76–92
Larson E. B., Yaffe K., Langa K. M., (2013) New insights into the dementia epidemic. The New England Journal of Medicine 369: 2275–2277
Lock M., (2013) The Alzheimer’s conundrum. Entanglements of dementia and aging, Princeton, NJ: Princeton University Press
Mak W., (2011) Self-reported goal pursuit and purpose in life among people with dementia. The Journals of Gerontology 66B: 177–184
Marcos G., Santabàrbara J., Lopez-Anton R., De-la-Càmara C., Gracia-Garcia P., Lobo E., Lobo A., (2016) Conversion to dementia in mild cognitive impairment diagnosed with DSM-5 criteria and with Petersen’s criteria. Acta Psychiatrica Scandinavica 133: 378–385
Matthews F. E., Stephan B. C. M., McKeith I. G., Bond J., Brayne C., and the Medical Research Council Cognitive Function and Ageing Study (2008) Two-year progression from mild cognitive impairment to dementia: To what extent do different definitions agree? Journal of the American Geriatrics Society 56: 1424–1433
Mattsson N., Rosén E., Hansson O., Andreasen N., Parnetti L., Jonsson M., Zetterberg H., (2012) Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology 78: 468–476
Miller Z. A., Mandelli M. L., Rankin K. P., Henry M. L., Babiak M. C., Frazier D. T., Gorno-Tempini L., (2013) Handedness and language learning disability differentially distribute in progressive aphasia variants. Brain 136: 3461–3473
Mitchell A. J., Shiri-Feskhi M., (2009) Rate of progression of mild cognitive impairment to dementia – Meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica 119: 252–265
Mungas D., Beckett L., Harvey D., Tomaszewski Farias S., Reed B., Carmichael O., DeCarli Ch., (2010) Heterogeneity of cognitive trajectories in diverse older persons. Psychology and Aging 25: 606–619
Neill D., (2012) Should Alzheimer’s disease be equated with human brain ageing? A maladaptive interaction between brain evolution and senescence. Ageing Research Reviews 11: 104–122
Ngandu T., Lehtisalo J., Solomon A., Levälahti E., Ahtiluoto S., Antikainen R., Kivipelto M., (2015) A 2 year multidomain intervention of diet, exercice, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. Lancet 385: 2255–2263
Nordström P., Nordström A., Eriksson M., Wahlund L.-O., Gustafson Y., (2013) Risk factors in late adolescence for young-onset dementia in men. A nation cohort study. JAMA Internal Medicine 173: 1612–1618
Park D. C., Rueter-Lorenz P. A., (2009) The adaptive brain: Aging and neurocognitive scaffolding. Annual Review of Psychology 60: 173–196
Power A. G., (2010) Dementia beyond drugs. Changing the culture of care, Baltimore: Health Professions Press
Reuter-Lorenz P. A., Park D. C., (2014) How does it STAC up? Revisiting the scaffolding theory of aging and cognition. Neuropsychological Review 24: 355–370
Richard E., Schmand B., Eikelenboom P., Westendorp R. G., Van Gool W. A., (2012) The Alzheimer myth and biomarker research in dementia. Journal of Alzheimer’s Disease 31: S203–S209
Rowe J. W., Kahn R. L., (1998) Successful aging, New York, NY: Random House
Rowe C. C., Ellis K. A., Rimajova M., Bourgeat P., Pike K. E., Jones G., Villemagne V. L., (2010) Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle study of aging. Neurobiology of Aging 31: 1275–1283
Satizabal C. L., Beiser A. S., Chouraki V., Chêne G., Dufouil C., Seshadri S., (2016) Incidence of dementia over three decades in the Framingham Heart Study. The New England Journal of Medicine 374: 523–531
Scheltens A. M. E., Galindo-Garre F., Pijnenburg Y. A., van der Vlies A. E., Smits L. L., Koene T., van der Flier W. M., (2016) The identification of cognitive subtypes in Alzheimer’s disease dementia using latent class analysis. Journal of Neurology, Neurosurgery and Psychiatry 87: 235–243
Schneider L. S., (2012) Could cholinesterase inhibitors be harmful overt the long term? International Psychogeriatrics 24: 171–174
Seifan A., Assuras S., Huey E. D., Mez J., Tsapanou A., Caccappolo E., (2015) Childhood learning disabilities and atypical dementia: A retrospective chart review. PLOS One 10(6): e0129919
Sona A., Zhang P., Ames D., Bush A. I., Lautenschlager N. T., Martins R. N., Ellis K. A., AIBL Research Group (2012) Predictors of rapid cognitive decline in Alzheimer’s disease: Results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of ageing. International Psychogeriatrics 24: 197–204
Song X., Mitnitski A., Zhang N., Chen W., Rockwood K., for the Alzheimer’s Disease Neuroimaging Initiative (2013) Dynamics of brain structure and cognitive function in the Alzheimer’s disease neuroimaging initiative. Journal of Neurology, Neurosurgery, and Neuropsychiatry 84: 71–78
Stephan B. C. M., Kurth T., Matthews F. E., Brayne C., Dufouil C., (2010) Dementia risk prediction in the population: Are screening models accurate? Nature Reviews Neurology 6: 318–326
Tricco A. C., Soobiah S., Beliner S., Ho J. M., Ng C. H., Ashoor H. M., Straus S. E., (2013) Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: A systematic review and meta-analysis. Canadian Medical Association Journal 185: 1393–1401
Tschanz J. T., Corcoran Ch. D., Schwartz S., Treiber K., Green R. C., Norton M. C., Rabins P. V., (2011) Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia. The Cache County Dementia Progression Study. American Journal of Geriatric Psychiatry 19: 532–542
Van der Linden M., Juillerat Van der Linden A.-C., (2014a) Penser autrement le vieillissement, Bruxelles: Mardaga
Van der Linden M., Juillerat Van der Linden A.-C., (2014b) L’évaluation neuropsychologique dans la démence: un changement d’approche. In: Seron X., Van der Linden M., (eds) Traité de neuropsychologie clinique de l’adulte, Paris: De Boeck-Solal, pp. 575–598
Ward A., Tardiff S., Dye C., Arrighi H. M., (2013) Rate of conversion from prodromal Alzheimer’s disease to Alzheimer’s dementia: A systematic review of the literature. Dementia and Geriatric Cognitive Disorders Extra 3: 320–332
Walhovd K. B., Fjell A. M., Epseseth T., (2014) Cognitive decline and brain pathology in aging – Need for a dimensional, lifespan and systems vulnerability view. Scandinavian Journal of Psychology 55: 244–254
Wharton S., Brayne C., Savva G., Matthews F. E., Forster G., Simpson J., Ince P., (2011) Epidemiological neuropathology: the MRC cognitive function and aging study experience. Journal of Alzheimer’s Disease 25: 359–372
Whitehouse P., (2013a) The challenges of cognitive aging: Integrating approaches from science to intergenerational relationships. Journal of Alzheimer’s Disease 36: 225–232
Whitehouse P., (2013b) The challenges of cognitive aging: Integrating approaches from science to intergenerational relationships. Journal of Intergenerational Relationships 11: 105–117
Whitehouse P., George D., (2008) The myth of Alzheimer's: What you aren't being told about today's most dreaded diagnosis, New York, NY: St Martin’s Press
Zeilig H., (2013) Dementia as a cultural metaphor. The Gerontologist 54: 258–267
